Kanishka Das Profile - Zacks Equity Research Blogger
4 Followers
Kanishka Das's Stock Coverage
| MRKMerck & Company | Nov 19, 2026 | Neutral | 6Ratings | +2.26% | ||
| HALOHalozyme | Nov 17, 2026 | Neutral | 1Ratings | ― | ― | |
| NKTRNektar Therapeutics | Oct 15, 2026 | Neutral | 2Ratings | -14.10% | ||
| RHHBYRoche Holding | Oct 14, 2026 | Bearish | 1Ratings | -9.40% | ||
| AZNAstraZeneca | Oct 14, 2026 | Bearish | 2Ratings | -6.55% | ||
| BMYBristol-Myers Squibb | Oct 14, 2026 | Bearish | 1Ratings | -6.10% | ||
| IRWDIronwood Pharma | Oct 07, 2026 | Bullish | 2Ratings | +25.70% | ||
| ABBVAbbVie | Oct 07, 2026 | Bullish | 1Ratings | +9.20% | ||
| PGENPrecigen | Sep 30, 2026 | Bullish | 4Ratings | -41.65% | ||
| INOInovio Pharmaceuticals | Sep 30, 2026 | Bullish | 4Ratings | +14.57% |
Disclaimer: TipRanks collects ratings of bloggers by scanning publicly available reports on financial websites and by receiving reports directly from the bloggers or from our users. The information displayed might not be accurate or up to date. The displayed ratings are made entirely at the sole discretion of the bloggers. TipRanks holds no liability over the bloggers information or opinions expressed on the site. See how TipRanks ranks experts and calculates performance.
